Mariner
AVNS

Mariner’s Avanos Medical AVNS Stock Holding History

Mariner’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Sell
9,727
-10,798
-53% -$253K ﹤0.01% 3005
2026
Q1 		$288K Buy
20,525
+1,567
+8% +$21.1K ﹤0.01% 2918
2025
Q4 		$213K Sell
18,958
-1,229
-6% -$14.1K ﹤0.01% 3120
2025
Q3 		$233K Buy
20,187
+6,322
+46% +$74K ﹤0.01% 3034
2025
Q2 		$170K Buy
+13,865
New +$174K ﹤0.01% 3105
2025
Q1 		– Sell
-10,655
Closed -$170K – 3447
2024
Q4 		$170K Buy
10,655
+1,625
+18% +$32.2K ﹤0.01% 3062
2024
Q3 		$217K Buy
+9,030
New +$206K ﹤0.01% 2875
2024
Q1 		– Sell
-16,069
Closed -$360K – 3140
2023
Q4 		$360K Buy
16,069
+2,778
+21% +$57.3K ﹤0.01% 2189
2023
Q3 		$269K Sell
13,291
-1,645
-11% -$37.3K ﹤0.01% 2257
2023
Q2 		$382K Buy
14,936
+4,015
+37% +$106K ﹤0.01% 1932
2023
Q1 		$325K Sell
10,921
-735
-6% -$21.3K ﹤0.01% 2005
2022
Q4 		$315K Sell
11,656
-106
-0.9% -$2.59K ﹤0.01% 1986
2022
Q3 		$256K Sell
11,762
-555
-5% -$14.5K ﹤0.01% 1880
2022
Q2 		$337K Buy
+12,317
New +$354K ﹤0.01% 1250

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Mariner's AVNS Position: Q2 2026 in Review

Mariner reduced its Avanos Medical (AVNS) stake by 53% in Q2 2026, selling an estimated $253K and leaving 9,727 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #3005.

Mariner first reported a position in AVNS in Q2 2022 and has held it in 14 quarters since. The position peaked at $382K in Q2 2023. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Mariner held 9,727 shares of Avanos Medical worth $242K as of Q2 2026.
  • Mariner sold 10,798 Avanos Medical shares in Q2 2026, an estimated $253K.
  • Avanos Medical made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3005 holding.
  • Mariner first reported a position in Avanos Medical in Q2 2022 and has held it in 14 quarters since.
  • Mariner's Avanos Medical position peaked at $382K in Q2 2023.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.